Recombinant Escherichia coli Putative transposon gamma-delta 80.3 kDa protein (tnpX)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times may vary based on purchasing method and location. Please consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. If you require dry ice shipment, please contact us in advance, as extra fees will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
tnpX; ECOK12F008; Putative transposon gamma-delta 80.3 kDa protein; Transposon Tn1000 protein TnpX
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-698
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
tnpX
Target Protein Sequence
MELNITSKSN PFGDTTAEND KKMLSNAFIE TADFRTLIET DDRTIVVGRR GTGKSALFIQ LNEHWKKDKK ILILSFSPDD SQIIGFRSML KPFTGSFNLA RAATRLLWRY AMLMEIASYI SSHYKLSSQI SSETLLNEHL KKWNSAQGDI LRKCRLVAKE YLDENNPEES IGDLQFNLNI SEIENNIVSL LERSDRKVVI LMDKLDEAYE PDNIGIGIIA GLAYASIELN QKAKCIRPII FLRDNIFRSL SKEDPDYSRN IEGQVIRLHW DWAQLLMLSA KRMKVAFKLD IEKDQRVWDR CTADDLKGRN GFKRCLQFTL YRPRDLLSLL NEAFFSAFRE NRETIINTDL EYAAKSISMA RLEDLWKEYQ KIFPSIQVIT SAFRSIEPEL TVYTCLKKIE ASFELIEENG DPKITSEIQL LKASGILQSL YSVGFVGIRD KNTSSYSFCH DGRTPDKGFE SNEKLLIHPC YWLGLNLNRN ALAPEEAEEI NDEYDINIIS DNSAIRNKTI GQITTHLDQI PIGNEGATEF EQWCLDALRI VFASHLTDIK SHPNGNAVQR RDIIGTNGGK SDFWKRVLED YKTRQVVFDA KNFEELGPSE YRQLQSYLTG PYGKLGFIIN RDESEVLKSG KDLDWTKEMY QSHNSLIIKL PAKYISKLLQ KLRNPEKHDA IDRQMGKLLT LYETSYMAIK STQKKRRK
Uniprot No.

Q&A

What is the putative transposon gamma-delta 80.3 kDa protein (tnpX) and what makes it significant for research?

The putative transposon gamma-delta 80.3 kDa protein (tnpX) is a large resolvase that plays a crucial role in the transposition mechanism of specific mobile genetic elements. Research has established that TnpX is the only transposon-encoded protein required for both excision and integration processes during transposition events in elements like Tn4451 and Tn4453, which are found in Clostridium perfringens and Clostridium difficile respectively . The self-sufficient nature of tnpX makes it an intriguing subject for understanding minimalist transposition systems and potentially developing genetic engineering tools.

tnpX functions through a serine recombinase-mediated site-specific recombination mechanism, allowing it to catalyze both the excision of transposon elements (producing circular intermediate molecules) and their subsequent integration into new genetic locations without requiring additional transposon proteins . This dual functionality differentiates tnpX from many other transposition systems that depend on multiple proteins working in concert.

How does tnpX compare structurally and functionally to other transposases?

Unlike many transposases that require multiple proteins for complete transposition, tnpX stands out for its self-sufficiency. In vivo and in vitro studies have confirmed that TnpX is uniquely capable of mediating both excision and integration reactions without other transposon-encoded factors . The protein belongs to the serine recombinase family, employing a catalytic mechanism distinct from the more common DDE transposases.

While detailed structural information about tnpX is limited in current literature, as a serine recombinase it likely contains an N-terminal catalytic domain with the conserved serine residue critical for DNA cleavage, a C-terminal DNA-binding domain for recognition of specific sequences, and domains facilitating the multimerization necessary for forming recombination complexes. Functional studies have shown that TnpX preferentially excises supercoiled DNA substrates, suggesting structure-dependent substrate recognition mechanisms .

What are the optimal conditions for expressing soluble recombinant tnpX in E. coli?

Based on established protocols for challenging recombinant proteins, successful expression of soluble tnpX in E. coli likely requires systematic optimization of multiple parameters. The following table summarizes key variables that should be considered:

ParameterRecommended RangeConsiderations
E. coli strainBL21(DE3), Rosetta, Arctic ExpressStrains with additional tRNAs may help if tnpX contains rare codons
Temperature15-25°CLower temperatures generally increase soluble protein yield
Induction OD6000.4-0.8Mid-log phase typically optimal for protein expression
Inducer concentration0.1-1.0 mM IPTGLower concentrations often favor soluble expression
Media compositionLB, TB, auto-inductionRich media can enhance yield but may increase inclusion body formation
Expression time4-16 hoursLonger times at lower temperatures often beneficial

A factorial design approach similar to that used for other recombinant proteins would be most effective for identifying optimal expression conditions . This would involve systematically testing combinations of these variables and measuring soluble protein yield and activity through appropriate assays.

What in vitro assay systems can reliably measure tnpX activity?

Given tnpX's function as a site-specific recombinase, several complementary assay systems can be employed to measure its activity:

  • In vitro excision assay: This approach utilizes a plasmid substrate containing appropriate recombination sites flanking a reporter gene. Upon successful tnpX-mediated excision, the formation of circular DNA products can be detected by gel electrophoresis and quantified. The reaction can be performed with purified tnpX protein and supercoiled plasmid substrate in a buffer system containing necessary cofactors such as divalent cations .

  • Targeted integration assay: Similar to methods developed for the Cas-Transposon system, this assay measures tnpX's ability to integrate DNA at specific target sites . The system requires:

    • Donor plasmid containing the transposon element

    • Target plasmid with potential integration sites

    • Purified tnpX protein

    The reaction products are transformed into competent E. coli, and transformants are analyzed to determine integration efficiency and specificity through colony PCR and sequencing of junction regions .

  • Quantitative PCR approach: For high-throughput screening of conditions or mutants, qPCR can detect and quantify specific DNA junctions resulting from tnpX-mediated recombination events, allowing for precise comparison of reaction efficiencies under different conditions.

A combination of these assays provides comprehensive characterization of both excision and integration activities, critical for understanding the complete functionality of recombinant tnpX.

What is the molecular mechanism of tnpX-mediated site-specific recombination?

The tnpX protein operates through a serine recombinase mechanism that involves several coordinated steps:

  • Site recognition and binding: tnpX recognizes specific DNA sequences at the transposon ends and target integration sites.

  • Synaptic complex formation: Multiple tnpX proteins assemble, bringing together the recombination sites in a precise three-dimensional arrangement.

  • DNA cleavage: A conserved serine residue in the catalytic domain of tnpX performs a nucleophilic attack on the DNA backbone, forming a covalent protein-DNA intermediate.

  • Strand exchange: The cleaved DNA strands undergo exchange through a subunit rotation mechanism characteristic of serine recombinases.

  • DNA religation: The DNA backbones are religated to complete the recombination event, resulting in either excision (circularization) or integration depending on the substrate configuration.

This complete process can occur without additional transposon-encoded proteins, indicating that tnpX contains all necessary functional domains to coordinate these complex biochemical reactions . The preference for supercoiled DNA substrates suggests that DNA topology plays an important role in this mechanism, potentially affecting recognition site accessibility or the energetics of the recombination reaction.

How can the Cas-Transposon fusion approach be applied to engineer targeted tnpX-based systems?

Drawing from advances with other transposases, the tnpX protein could potentially be engineered as a programmable site-directed DNA integration tool similar to the Cas-Transposon (CasTn) system developed with Himar1 transposase . Such a system would fuse tnpX with a programmable DNA-binding domain like dCas9, creating a hybrid protein capable of targeted integration.

The core engineering principles would include:

  • Fusion protein design: tnpX could be fused to dCas9 using flexible protein linkers like XTEN that preserve the activity of both domains . The optimal configuration (N- or C-terminal fusion) would need to be determined experimentally.

  • Activity validation: Both in vitro and in vivo assays would be required to verify that:

    • The fusion protein retains DNA binding specificity guided by gRNAs

    • The transposase activity of tnpX remains functional

    • The combined protein can perform site-directed transposition

  • Optimization parameters: Key factors to optimize would include:

    • Protein expression conditions (3-100 nM protein concentrations have shown effectiveness for similar systems)

    • DNA substrate ratios (donor:target plasmid ratios)

    • Buffer conditions and reaction temperatures

    • gRNA design for optimal targeting

Based on data from similar systems, such an engineered tnpX-dCas9 fusion could potentially increase the frequency of targeted transposition by >300-fold compared to random integration , making it a powerful tool for precise genetic engineering.

What factors influence target site selection during tnpX-mediated integration?

Target site selection by tnpX involves a complex interplay of factors that can be investigated through systematic approaches:

  • DNA sequence preferences: While specific tnpX target site preferences aren't fully characterized, similar resolvases typically recognize specific DNA motifs. These preferences could be mapped through:

    • Next-generation sequencing of integration sites

    • In vitro selection experiments with randomized target sequences

    • Comparative analysis of natural integration sites

  • DNA topology effects: Studies have shown that TnpX preferentially excises supercoiled DNA substrates , suggesting that DNA topology significantly influences recombination efficiency. This could be experimentally tested by comparing integration rates into relaxed versus supercoiled target plasmids.

  • Target accessibility: In cellular contexts, chromatin structure and DNA-binding proteins likely affect target site availability. These effects could be studied by:

    • Comparing integration patterns in different cell types

    • Analyzing integration near known DNA-binding protein sites

    • Manipulating chromatin structure and observing effects on targeting

  • Experimental manipulation: For engineered systems, targeting could be influenced by fusion to DNA-binding domains as demonstrated with the Himar–dCas9 system, where gRNA design and concentration significantly affected targeting specificity .

Understanding these factors would not only provide fundamental insights into tnpX biology but also enable the development of more precise genetic engineering tools.

How can researchers overcome common challenges in tnpX protein solubility and activity?

Large DNA-binding proteins like tnpX often present challenges for soluble expression and maintaining activity. Researchers can implement several strategies to address these issues:

  • Improving solubility:

    • Fusion tags: MBP, SUMO, or thioredoxin tags can significantly enhance solubility

    • Co-expression with chaperones: GroEL/GroES, DnaK/DnaJ, or Trigger Factor

    • Solubility-enhancing mutations: Identified through directed evolution or rational design

    • Expression in specialized E. coli strains like ArcticExpress or SHuffle that facilitate proper folding

  • Maintaining activity:

    • Buffer optimization: Testing various pH ranges (typically 7.0-8.5) and salt concentrations

    • Addition of stabilizing agents: Glycerol (10-20%), reducing agents, and specific metal ions

    • DNA binding partners: Including specific DNA sequences recognized by tnpX can sometimes stabilize the protein

    • Storage conditions: Flash freezing in small aliquots with cryoprotectants

  • Activity enhancement:

    • Protein engineering: Creating hyperactive variants through targeted mutagenesis

    • Reaction condition optimization: Systematic testing of buffer components, temperature, and incubation times

    • Macromolecular crowding agents: PEG or Ficoll can sometimes enhance in vitro activity by mimicking cellular conditions

These approaches should be evaluated systematically using appropriate activity assays to determine which combination provides optimal results for specific experimental goals.

What experimental design approaches are most effective for optimizing recombinant tnpX expression?

Systematic experimental design is crucial for efficient optimization of recombinant tnpX expression. A factorial design approach allows researchers to efficiently explore multiple variables simultaneously:

  • Design of Experiments (DoE) methodology:

    • Factorial designs enable testing multiple variables with fewer experiments than one-factor-at-a-time approaches

    • For tnpX expression, an initial 2^8-4 fractional factorial design could test 8 variables with just 16 experiments

    • Variables typically include: temperature, inducer concentration, media composition, expression time, strain, vector, pH, and additives

  • Response surface methodology (RSM):

    • After identifying significant factors, RSM can fine-tune optimal conditions

    • This approach plots response variables (protein yield, activity) against experimental factors to identify optimal ranges

  • High-throughput screening:

    • Micro-scale cultures (deep-well plates) allow rapid testing of many conditions

    • Automated protein purification and activity assays enable rapid evaluation

    • Fluorescent reporters fused to tnpX can provide real-time solubility data

  • Statistical analysis:

    • ANOVA to determine which factors significantly affect expression

    • Interaction effects often reveal non-obvious combinations of conditions

    • Predictive models can guide further optimization

This systematic approach has been successfully applied to other challenging recombinant proteins and could significantly reduce the time and resources needed to optimize tnpX expression while providing more reliable and reproducible results.

How can recombinant tnpX be leveraged for precision genome engineering applications?

The self-sufficient nature of tnpX makes it a promising candidate for developing novel genome engineering tools:

  • Programmable integration systems:

    • Fusion of tnpX with programmable DNA-binding domains like dCas9 could create targeted integration tools

    • Such systems could potentially achieve site-directed transposition with >300-fold specificity compared to random integration

    • Applications include precise transgene insertion for cell engineering and gene therapy

  • Genetic circuit design:

    • tnpX-mediated recombination could create genetic switches or memory elements

    • Inducible expression of tnpX could control the timing of genetic rearrangements

    • These systems could enable sophisticated synthetic biology applications requiring programmed DNA rearrangements

  • Transgenesis applications:

    • tnpX-based systems could facilitate more efficient integration of transgenes in difficult-to-transform organisms

    • The compact nature of tnpX (requiring no additional factors) makes it suitable for delivery via various vectors

  • Multiplexed genome engineering:

    • Multiple tnpX variants recognizing different target sequences could enable simultaneous integration at multiple genomic locations

    • This approach could facilitate complex pathway engineering requiring multiple gene insertions

Engineering tnpX for these applications would require detailed characterization of its recognition sequences, optimization of reaction conditions, and potentially protein engineering to modify its targeting capabilities, similar to approaches used with the Himar1 transposase in the CasTn system .

What are the comparative advantages of tnpX-based systems versus other site-specific recombination tools?

When evaluating tnpX as a genetic engineering tool, several distinct advantages and limitations emerge in comparison with established systems:

FeaturetnpX SystemCre/loxPCRISPR-Cas9Sleeping Beauty/PiggyBac
Self-sufficient activitySingle protein required for both excision and integration Requires pre-positioned recombination sitesRequires tracrRNA and crRNA/gRNARequires transposase plus recognition sequences
Target site flexibilityNatural preference for specific sequences that could potentially be engineeredFixed recognition of loxP sitesHighly programmable via gRNA designSemi-random integration with sequence preferences
Reaction reversibilityCan mediate both integration and excisionReversible recombinationNot inherently reversibleIntegration more efficient than excision
DNA capacityLikely capable of mobilizing large DNA fragmentsDecreasing efficiency with increasing DNA sizeNot an integration system by itselfCapability for relatively large cargo (up to 10kb)
Immunogenicity concernsBacterial origin may trigger immune responses in therapeutic applicationsBacterial origin with established immunogenicity profileBacterial origin requires careful delivery for therapeutic useNon-human origin requires immunogenicity testing

The primary advantage of tnpX is its self-contained nature, requiring no additional transposon proteins for both excision and integration functions . This simplifies system design and delivery for genetic engineering applications. Furthermore, if tnpX could be engineered for programmable targeting similar to the Himar-dCas9 fusion , it could combine the integration efficiency of transposases with the targeting precision of CRISPR systems.

The development of tnpX-based tools would be particularly valuable for applications requiring precise DNA integration in contexts where CRISPR-mediated homology-directed repair is inefficient and where predetermined recombination sites (as required by Cre/loxP) are not feasible.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.